Agrawal N, Ates LS, Schille SA, Chaturvedi A, et al. mRNA-based tuberculosis vaccines BNT164a1 and BNT164b1 are immunogenic, well tolerated and efficacious in rodent models. Nat Immunol 2026 Jun 12. doi: 10.1038/s41590-026-02545.
PMID: 42286358